Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells

  1. Zsuzsa Szondya,b,c,
  2. Zsolt Saranga,b,
  3. Péter Molnárd,
  4. Tamás Némethd,
  5. Mauro Piacentinie,
  6. Pier Giorgio Mastroberardinof,
  7. Laura Falascae,
  8. Daniel Aeschlimanng,
  9. Judit Kovácsd,
  10. Ildikó Kissa,
  11. Éva Szegezdia,
  12. Gabriella Lakosh,
  13. Éva Rajnavölgyii,
  14. Paul J. Birckbichlerj,
  15. Gerry Melinok,l, and
  16. László Fésüsa
  1. aDepartment of Biochemistry and Molecular Biology, Research Center for Molecular Medicine, dDepartment of Pathology, hThird Department of Medicine, iInstitute of Immunology, University of Debrecen, Debrecen H-4012, Hungary; eNational Institute of Infectious Diseases “La Spallanzani,” 00149 Rome, Italy; Departments of fBiology and kExperimental and Biochemical Science, University of Tor Vergata, 00133 Rome, Italy; gMatrix Biology and Tissue Repair Research Unit, Dental School, University of Wales College of Medicine, Cardiff CF14 4XY, Wales, United Kingdom; jDepartment of Chemistry, Slippery Rock University, Slippery Rock, PA 16057; and lMedical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Leicester LE1 9HN, United Kingdom
  1. Communicated by Laszlo Lorand, Northwestern University Medical School, Chicago, IL, April 25, 2003 (received for review February 20, 2002)

Abstract

Tissue transglutaminase (TGase2) is a protein-crosslinking enzyme known to be associated with the in vivo apoptosis program. Here we report that apoptosis could be induced in TGase2-/- mice; however, the clearance of apoptotic cells was defective during the involution of thymus elicited by dexamethasone, anti-CD3 antibody, or γ-irradiation, and in the liver after induced hyperplasia. The lack of TGase2 prevented the production of active transforming growth factor-β1 in macrophages exposed to apoptotic cells, which is required for the up-regulation of TGase2 in the thymus in vivo, for accelerating deletion of CD4+CD8+ cells and for efficient phagocytosis of apoptotic bodies. The deficiency is associated with the development of splenomegaly, autoantibodies, and immune complex glomerulonephritis in TGase2-/- mice. These findings have broad implications not only for diseases linked to inflammation and autoimmunity but also for understanding the interrelationship between the apoptosis and phagocytosis process.

Footnotes

  • c To whom correspondence should be addressed. E-mail: szondy{at}indi.dote.hu.

  • b Z. Szondy and Z. Sarang contributed equally to this work.

  • Abbreviations: TGase, transglutaminase; TGF-β, transforming growth factor β.

« Previous | Next Article »Table of Contents